Yoon Jiyoon, Sivakumar Parthipan, O'Kane Kevin, Ahmed Liju
Department of Respiratory Medicine, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
Department of Emergency Medicine, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
Int J Emerg Med. 2017 Dec;10(1):9. doi: 10.1186/s12245-017-0135-x. Epub 2017 Feb 21.
The key guidelines in the management of primary spontaneous pneumothorax (PSP) include the 2010 British Thoracic Society (BTS) Pleural Disease guideline and 2001 American College of Chest Physicians (ACCP) Consensus Statement. Current recommendations are dependent on radiographic measures which differ between these two guidelines. The aim of this study is to compare size classification of PSP cases, according to BTS and ACCP guidelines, and to evaluate guideline compliance.
We conducted a retrospective evaluation of all PSP episodes presenting to St Thomas' Hospital, London, between February 2013 and December 2014. Data was recorded from review of chest X-rays and patient records. Eighty-seven episodes of PSP in 72 patients were identified (median age 25 years, IQR 22-32.25). Classification of "large" and "small" showed the greatest disparity in those managed conservatively (12/27, 44%) or with aspiration only (11/23, 48%). In this UK study, BTS guidelines were followed in 70% of episodes with adherence to ACCP guidelines in 32% of episodes.
There is a poor agreement in size classification between BTS and ACCP guidelines, resulting in conflicting recommendations for management of PSP. Robust clinical trial evidence is required to achieve international consensus on the management of PSP.
原发性自发性气胸(PSP)管理的关键指南包括2010年英国胸科学会(BTS)胸膜疾病指南和2001年美国胸科医师学会(ACCP)共识声明。当前的建议依赖于影像学测量,而这两个指南中的测量方法有所不同。本研究的目的是根据BTS和ACCP指南比较PSP病例的大小分类,并评估指南的依从性。
我们对2013年2月至2014年12月期间在伦敦圣托马斯医院就诊的所有PSP发作进行了回顾性评估。数据通过胸部X光片和患者记录回顾进行记录。共识别出72例患者的87次PSP发作(中位年龄25岁,四分位间距22 - 32.25岁)。“大”和“小 ” 的分类在保守治疗(12/27,44%)或仅行穿刺抽吸治疗(11/23,48%)的患者中差异最大。在这项英国研究中,70%的发作遵循BTS指南,32%的发作遵循ACCP指南。
BTS和ACCP指南在大小分类方面的一致性较差,导致PSP管理的建议相互冲突。需要有力的临床试验证据来达成关于PSP管理的国际共识。